SEER
Price:
$2.21
Market Cap:
$130.32M
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk ...[Read more]
Industry
Biotechnology
IPO Date
2020-12-04
Stock Exchange
NASDAQ
Ticker
SEER
According to Seer, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 119.19M. This represents a change of 11.40% compared to the average of 107.00M of the last 4 quarters.
The mean historical Enterprise Value of Seer, Inc. over the last ten years is 1.55B. The current 119.19M Enterprise Value has changed 666.92% with respect to the historical average. Over the past ten years (40 quarters), SEER's Enterprise Value was at its highest in in the September 2020 quarter at 3.28B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
1.55B
Median
1.18B
Minimum
119.63M
Maximum
3.42B
Discovering the peaks and valleys of Seer, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 189.87%
Maximum Annual Enterprise Value = 3.42B
Minimum Annual Increase = -71.26%
Minimum Annual Enterprise Value = 119.63M
Year | Enterprise Value | Change |
---|---|---|
2023 | 119.63M | -64.69% |
2022 | 338.78M | -71.26% |
2021 | 1.18B | -61.80% |
2020 | 3.09B | -9.81% |
2019 | 3.42B | 189.87% |
The current Enterprise Value of Seer, Inc. (SEER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
545.74M
5-year avg
1.63B
10-year avg
1.55B
Seer, Inc.’s Enterprise Value is less than ORIC Pharmaceuticals, Inc. (536.83M), greater than Anebulo Pharmaceuticals, Inc. (40.61M), less than Cullinan Oncology, Inc. (614.81M), less than C4 Therapeutics, Inc. (280.63M), greater than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (539.76M), greater than AN2 Therapeutics, Inc. (7.13M), less than Pharvaris N.V. (672.28M), greater than PepGen Inc. (108.11M), less than Foghorn Therapeutics Inc. (260.47M), greater than Shattuck Labs, Inc. (12.78M), less than Monte Rosa Therapeutics, Inc. (351.25M), less than Kymera Therapeutics, Inc. (2.62B), less than Nurix Therapeutics, Inc. (1.31B), less than Quantum-Si incorporated (157.08M), greater than HCW Biologics Inc. (26.86M), greater than MediciNova, Inc. (59.45M), less than Nkarta, Inc. (194.33M), less than Lyell Immunopharma, Inc. (130.21M), less than Generation Bio Co. (143.59M), less than Sana Biotechnology, Inc. (359.81M),
Company | Enterprise Value | Market cap |
---|---|---|
536.83M | $577.94M | |
40.61M | $42.01M | |
614.81M | $714.45M | |
280.63M | $273.18M | |
107.67M | $195.74M | |
539.76M | $637.04M | |
7.13M | $40.64M | |
672.28M | $1.02B | |
108.11M | $131.36M | |
260.47M | $279.08M | |
12.78M | $52.99M | |
351.25M | $433.13M | |
2.62B | $2.64B | |
1.31B | $1.39B | |
157.08M | $185.53M | |
26.86M | $15.05M | |
59.45M | $101.53M | |
194.33M | $165.84M | |
130.21M | $179.07M | |
143.59M | $71.47M | |
359.81M | $390.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seer, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Seer, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Seer, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Seer, Inc. (SEER)?
What is the 3-year average Enterprise Value for Seer, Inc. (SEER)?
What is the 5-year average Enterprise Value for Seer, Inc. (SEER)?
How does the current Enterprise Value for Seer, Inc. (SEER) compare to its historical average?